Literature DB >> 2070343

Functions and activities of the Area Committee on Microbiology of the National Committee for Clinical Laboratory Standards.

J A Washington1.   

Abstract

The Area Committee on Microbiology of the National Committee for Clinical Laboratory Standards has responsibility for the development of guidelines and standards in the field of clinical microbiology. Through the consensus process, representatives from government, industry, and professional societies have developed standards on antibacterial susceptibility testing (M2, M7, and M11), antimycobacterial susceptibility testing (M24), quality assurance on commercially prepared microbiological culture media (M22), evaluation of production lots of dehydrated Mueller-Hinton agar (M6), and preparation and testing of fetal bovine serum for use as cell culture growth supplement (M25) and guidelines on bactericidal tests (M26), protection of laboratory workers from infections transmitted by blood, body fluids, and tissue (M29), blood film examination for parasites (M15), and development of in vitro susceptibility testing criteria and quality control parameters (M23).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2070343      PMCID: PMC358187          DOI: 10.1128/CMR.4.2.150

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  15 in total

1.  Selection of a reference lot of Mueller-Hinton agar.

Authors:  H M Pollock; A L Barry; T L Gavan; P C Fuchs; S Hansen; C L Thornsberry; H Frankel; S B Forsythe
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

Review 2.  Antibiotic tolerance among clinical isolates of bacteria.

Authors:  S Handwerger; A Tomasz
Journal:  Rev Infect Dis       Date:  1985 May-Jun

3.  Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests.

Authors:  C C Sanders; J P Iaconis; G P Bodey; G Samonis
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

Review 4.  Antifungal susceptibility tests.

Authors:  J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

5.  Multicenter evaluation of four methods of yeast inoculum preparation.

Authors:  M A Pfaller; L Burmeister; M S Bartlett; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

6.  Collaborative investigation of variables in susceptibility testing of yeasts.

Authors:  M A Pfaller; M G Rinaldi; J N Galgiani; M S Bartlett; B A Body; A Espinel-Ingroff; R A Fromtling; G S Hall; C E Hughes; F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

7.  Cation components of Mueller-Hinton agar affecting testing of Pseudomonas aeruginosa susceptibility to gentamicin.

Authors:  M A Kenny; H M Pollock; B H Minshew; E Casillas; F D Schoenknecht
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

8.  Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin.

Authors:  L P Garrod; P M Waterworth
Journal:  J Clin Pathol       Date:  1969-09       Impact factor: 3.411

9.  Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.

Authors:  J A Washington; R J Snyder; P C Kohner; C G Wiltse; D M Ilstrup; J T McCall
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

10.  Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo.

Authors:  A L Barry; G H Miller; C Thornsberry; R S Hare; R N Jones; R R Lorber; R Ferraresi; C Cramer
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

View more
  1 in total

1.  In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures.

Authors:  E Potgieter; M Carmichael; H J Koornhof; L J Chalkley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.